Opportunity Information: Apply for RFA NS 23 002

This NIH funding opportunity (RFA-NS-23-002) supports a U24 cooperative agreement to build and share practical tools and community-facing resources that help researchers interpret what vascular-related signals seen on in vivo brain imaging actually mean at the underlying tissue and vessel level, especially in traumatic brain injury (TBI)-related dementia and vascular contributions to cognitive impairment and dementia (VCID), as well as other Alzheimer’s disease-related dementias (ADRD). The central idea is to close a persistent gap between what clinicians and researchers observe on neuroimaging scans during life (for example, imaging patterns suggestive of small vessel disease or other vascular injury) and what neuropathology can confirm and explain after tissue-based examination. Projects are expected to strengthen combined human neuropathology and neuroimaging research so that imaging findings can be tied more directly to specific vascular pathophysiology, improving the field’s ability to understand mechanisms and, ultimately, to interpret clinically relevant imaging markers with more confidence.

The FOA emphasizes the development and distribution of “enabling” resources rather than running clinical trials. That typically means creating innovative technologies, standardized methods, validated protocols, and biomedical materials that other investigators can adopt broadly. The resources should be designed to expand the research community’s capacity to do neuropathologically informed neuroimaging research focused on VCID and TBI-related dementia. In practice, that could include things like harmonized approaches for collecting, processing, and analyzing imaging and tissue data across sites; methods to align or correlate imaging features with neuropathologic measures; reference datasets or atlases that link imaging signatures to vascular lesions; shared pipelines, quality-control procedures, or analytic frameworks; or physical or digital biomedical materials that make these studies easier to reproduce and scale.

A major requirement is open sharing. The FOA makes clear that resources produced under this initiative must follow open data-sharing practices, with the intent that the outputs do not stay within a single lab or consortium but instead become broadly accessible to the wider community. The emphasis on distribution matters: applicants are expected not only to build tools and protocols, but also to package them in a way that encourages adoption, reuse, and consistent implementation by other groups working on VCID, TBI-related dementia, and related ADRD conditions. The cooperative agreement mechanism also signals substantial NIH involvement, meaning awardees should expect active coordination with NIH program staff and alignment with program goals, milestones, and community needs.

Eligibility is broad across U.S.-based organizations. Eligible applicants include a range of government entities (state, county, city/township, special districts), school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized tribal governments, and tribal organizations that are not federally recognized. Nonprofits are eligible whether they have 501(c)(3) status or not, and for-profit organizations (other than small businesses) and small businesses can also apply. The FOA explicitly notes interest in applications from institutions that serve historically underrepresented communities, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as eligible federal agencies and faith-based or community-based organizations. U.S. territories or possessions and regional organizations are also included among “other eligible applicants.”

Foreign institutions are not eligible to apply as primary applicants, and non-U.S. components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined by the NIH Grants Policy Statement, meaning a U.S. applicant may be able to include certain international elements in the project when well-justified and compliant with NIH policy, even though the applicant organization itself must be U.S.-based.

Administratively, the opportunity is categorized as a discretionary NIH program, with a cooperative agreement funding instrument and a health-related activity category (CFDA/Assistance Listing numbers 93.853 and 93.866). The original closing date listed is March 17, 2023, and the FOA is explicitly “Clinical Trials Not Allowed,” reinforcing that the expected work product is shared infrastructure, methods, and resources rather than interventional human studies.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in TBI-related dementia and/or VCID (U24 - Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
  • This funding opportunity was created on 2023-01-06.
  • Applicants must submit their applications by 2023-03-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA NS 23 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)

Previous opportunity: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA NS 23 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA NS 23 002) also looked into and applied for these:

Funding Opportunity
Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) Apply for PAR 23 092

Funding Number: PAR 23 092
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) Apply for PAR 23 094

Funding Number: PAR 23 094
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for PAR 23 097

Funding Number: PAR 23 097
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Apply for PAR 23 091

Funding Number: PAR 23 091
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Apply for PAR 23 093

Funding Number: PAR 23 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) Apply for PAR 23 095

Funding Number: PAR 23 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) Apply for RFA OD 23 001

Funding Number: RFA OD 23 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) Apply for PAR 23 070

Funding Number: PAR 23 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) Apply for PAR 23 071

Funding Number: PAR 23 071
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Apply for RFA NS 23 012

Funding Number: RFA NS 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) Apply for PAR 23 082

Funding Number: PAR 23 082
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 24 004

Funding Number: RFA HL 24 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $317,000
Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 003

Funding Number: RFA HL 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) Apply for PAR 23 073

Funding Number: PAR 23 073
Agency: National Institutes of Health
Category: Health
Funding Amount: $75,000
Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional) Apply for RFA HL 24 001

Funding Number: RFA HL 24 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $281,250
Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed) Apply for RFA DE 23 014

Funding Number: RFA DE 23 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 002

Funding Number: RFA HL 24 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,105,263
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) Apply for PAR 23 061

Funding Number: PAR 23 061
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional) Apply for PAR 23 060

Funding Number: PAR 23 060
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) Apply for PAR 23 062

Funding Number: PAR 23 062
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 23 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: